Navigation Links
SAFC Hitech(TM) Expands Sheboygan Facility With State-of-the-Art Manufacturing Cleanroom
Date:4/28/2008

m manufacturing and services group within Sigma-Aldrich that focuses on products and services for high technology applications, cell culture products and services for biopharmaceutical manufacturing, biochemical production and the manufacturing of complex, multi-step organic synthesis of APIs and key intermediates. SAFC has manufacturing facilities around the world dedicated to providing manufacturing services for companies requiring a reliable partner to produce their custom manufactured materials. SAFC has four focus areas -- SAFC Pharma(TM), SAFC Supply Solutions(R), SAFC Biosciences(TM), and SAFC Hitech(TM) -- and had annual sales of nearly $600 million in 2007. SAFC is one of the world's 10 largest fine chemical businesses. For more information about SAFC, visit http://www.safcglobal.com.

About Sigma-Aldrich: Sigma-Aldrich is a leading Life Science and High Technology company. Our biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high technology manufacturing. We have customers in life science companies, university and government institutions, hospitals and in industry. Over one million scientists and technologists use our products. Sigma-Aldrich operates in 36 countries and has 7,900 employees providing excellent service worldwide. We are committed to accelerating Customers' success through leadership in Life Science, High Technology and Service. For more information about Sigma-Aldrich, please visit our award-winning web site at http://www.sigma-aldrich.com.

Cautionary Statement: This release contains forward-looking statements relating to future performance, goals, strategic actions and initiatives and similar intentions and beliefs and other statements regarding the Company
'/>"/>

SOURCE Sigma-Aldrich
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. SAFC Hitech(TM) Joins Aviza and ST Microelectronics for Solid State Technology ALD Webcast
2. SAFC Hitech(TM) Plans Further Expansion Into Asia
3. ATS Medical Expands Open Pivot Heart Valve Offerings
4. SAFC Expands Hi-Potency API Manufacturing and Introduces Solid-Form Testing at Its Madison Facility
5. BioLife Solutions Expands Scientific Advisory Board
6. Elekta To Showcase Innovations in Radiotherapy and Unveil New Product That Expands Cancer Treatment Availability
7. SAFC Expands European Commercial Manufacturing and Storage Capacities With $10 Million Investment
8. Pharsight Expands Strategic Consulting Services Team
9. Validus Pharmaceuticals Expands Product Portfolio with Acquisition of Bipolar Drug: Equetro(R)
10. Serica Technologies Expands Facilities in Massachusetts, Combines State-Of-The-Art Textile Engineering and Biomedical Manufacturing
11. AQUISS Expands Into Significant New Territory

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...ire/ -- "Micro cap and small cap equities across t...onsorship and exposure as a ,buying window, opens ...riven stocks like gold, silver and other metals," ...Inc, Manhattan based investor relations firm with ...rket in the US and Canada, and with expansion plan...
(Date:11/9/2009)...wire-FirstCall/ -- BioMed Realty Trust, Inc. (NYSE...ived commitments from lenders to increase the borr...$65 million to an aggregate of $665 million, with ...e weighted-average effective interest rate of the ... 30, 2009. The maturity date remains August 1, 201...
(Date:11/9/2009)...ewswire-Asia/ -- The pharma and biotech sectors ar...anies are facing significant,pressure to change wi... calls for,lower prices and a greater regulatory b...l crisis have made the work of creating new drugs ... being forced to globalize their R&D,operation...
(Date:11/9/2009)...wswire-FirstCall/ -- CEL-SCI Corporation (NYSE Ame...nthal, Professor of Immunology and Microbiology of...e and Pharmacy, reported on work conducted in coll...and CEL-SCI on CEL-SCI,s LEAPS vaccine technology....: "All Things Considered" Conference in Crystal Ci...
Breaking Biology Technology:Haft Group says Bullish Commodity Market Triggers Small and Micro-cap Upsurge 2BioMed Realty Trust Receives Commitments to Expand Unsecured Line of Credit to $665 Million 2BioMed Realty Trust Receives Commitments to Expand Unsecured Line of Credit to $665 Million 3Pharma and Biotech Leaders to Converge in Shanghai 2CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response 2CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response 3
...IX, Nov. 6 NutraCea (OTC Bulletin Board:,NTRZ), a...ent research and,technology announced today that i...position of Chief Financial Officer. Todd Crow, in...ns, has retired as CFO, but will remain,available ...ndez-Longan has over 20 years of financial experie...
...rd quarter net loss narrows on higher revenue due ...nterMune, Inc.,(Nasdaq: ITMN ) today announced re...ne months ended September 30, 2008. InterMune repo...12.5 million, or $0.32 per share,compared with a n...he third,quarter of 2007., Dan Welch, Chairman, C...
..., Pa., Nov. 6 ViroPharma Incorporated,(Nasdaq: V...nt and chief,executive officer of ViroPharma, will...estment Conference at 12:25 P.M. ET on Wednesday, ... the New York Palace Hotel., ViroPharma also anno...ntific officer of ViroPharma will present at the L...
Other Biology Technology:NutraCea Appoints New Chief Financial Officer 2InterMune Reports Third Quarter 2008 Financial Results and Business Highlights 2InterMune Reports Third Quarter 2008 Financial Results and Business Highlights 3InterMune Reports Third Quarter 2008 Financial Results and Business Highlights 4InterMune Reports Third Quarter 2008 Financial Results and Business Highlights 5InterMune Reports Third Quarter 2008 Financial Results and Business Highlights 6InterMune Reports Third Quarter 2008 Financial Results and Business Highlights 7InterMune Reports Third Quarter 2008 Financial Results and Business Highlights 8InterMune Reports Third Quarter 2008 Financial Results and Business Highlights 9ViroPharma to Present at Three November Healthcare Conferences 2
(Date:11/9/2009)...nia and elsewhere provide support for the use of m...d protecting marine habitats, according to biologi..., A recent study in the Gulf of California, for ...ehind marine reserves--the idea that offspring pro... of harvested species outside the reserve. , "It...
(Date:11/9/2009)...ad their hands tied because more than half of all ...n called p53. As a critical anti-cancer watchdog, ... within cells. When cells lose p53, tumors grow ag... tumors might be tough, but they,re not invincible...oratory (CSHL). The chink in the tumors, armor, ac...
(Date:11/9/2009)...researchers has completed a first draft of the cas... important first step in accelerating the pace of ...ome of the many limitations that face cassava farm...hat serves as the primary food source for more tha...y properties that make it an important food across...
Breaking Biology News(10 mins):Studies show marine reserves can be an effective tool for managing fisheries 2Studies show marine reserves can be an effective tool for managing fisheries 3Studies show marine reserves can be an effective tool for managing fisheries 4Studies show marine reserves can be an effective tool for managing fisheries 5CSHL study shows that some malignant tumors can be shut down after all 2CSHL study shows that some malignant tumors can be shut down after all 3Researchers complete draft genome sequence for cassava 2Researchers complete draft genome sequence for cassava 3Researchers complete draft genome sequence for cassava 4Nurses File Cal OSHA Complaint After Hospital Refuses to Supply Swine Flu Masks for Units with Infected Patients 51699 1Nurses File Cal OSHA Complaint After Hospital Refuses to Supply Swine Flu Masks for Units with Infected Patients 51699 2Nurses File Cal OSHA Complaint After Hospital Refuses to Supply Swine Flu Masks for Units with Infected Patients 51699 3HLTH and WebMD Announce Second Quarter Earnings Release Date and Conference Call 51697 1HLTH and WebMD Announce Second Quarter Earnings Release Date and Conference Call 51697 2YAI NIPD Board of Trustees Elects Eliot Green Chair and Sheldon Kwiat Vice Chair 51695 1YAI NIPD Board of Trustees Elects Eliot Green Chair and Sheldon Kwiat Vice Chair 51695 2YAI NIPD Board of Trustees Elects Eliot Green Chair and Sheldon Kwiat Vice Chair 51695 3
...OZEMAN -- The U.S. Department of Energy on Monday ...tration Partnership at Montana State University to... carbon dioxide into the sandstone rock layer bene...hird and final phase of federal funding for the Bi...ately $14 million of the federal money will stay o...
...ovember 17, 2008 (Bronx, NY) A team of researche...lege of Medicine of Yeshiva University has determi...ay have the unintended consequence of increasing t...inding could alter the way doctors prescribe migra... the journal Headache , the Einstein-led study of...
...Two new compounds created by a University of Centr...ying breast cancer tumors. , Associate Professor ...d spread of breast cancer tumors in tests on mice.... cancer-causing protein called STAT3, and research... , "The compounds are very promising," Turkson sa...
Other Biology News:Montana State partnership receives $66.9M for carbon sequestration 2Montana State partnership receives $66.9M for carbon sequestration 3Overuse of narcotics and barbiturates may make migraine worse 2Two new compounds show promise for eliminating breast cancer tumors 2
7500 Series ICP-MS ChemStation Upgrade from Agilent Technologies
File Holder from Terra Universal, Inc.
...for genome-wide microRNA expression profiling and ...uidic on-chip synthesis platform. These microarray...RNA Expression Profiling Service. Probe Content ...n mammal microRNAs (802 unique mature sequences). ...
...on is critical to the maintenance of appropriate l...portant and diverse as those involved in cellular ...n presentation, modulation of cell surface recepto...ription, and signalling factors. The ubiquitin-pro...
Biology Products: